NEXT

Law.com

What's Next: Trump's Longshot Big Tech Suits Might Not Deter Similar Litigation + What Happened to 'Most Important' Evidence in Theranos Case? + Elon Musk Calls Attorney a 'Bad Human Being'

First Amendment lawyers say Trump's lawsuits against Big Tech are likely doomed, but that might not deter similar litigation.
9 minute read

The Recorder

Hausfeld Hits Biotech Robotics Developer With Proposed Antitrust Class Action

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read

The Recorder

Theranos' Elizabeth Holmes Claims Government Failed to Preserve the Most Important Exculpatory Evidence in Fraud Case

Prosecutors allege that the evidence, a database of test result information, was a dead end, and if anything, would have helped them prove their case against the Theranos founder and CEO.
4 minute read

National Law Journal

Federal Circuit Resumes In-Person Argument With $1.2 Billion Cancer Drug Case

Orrick's Joshua Rosenkranz and Irell's Morgan Chu squared off over Gilead Sciences' Yescarta CAR-T therapy. Chief Judge Kimberly Moore pressed Chu repeatedly on whether Sloan Kettering had sufficiently described its patent on a groundbreaking approach to cancer treatment.
5 minute read

Delaware Business Court Insider

Chancery Rules Against CEO Over 'Self-Help' in Dispute Over Contract Breach

The case stems from a contract between Macrophage Therapeutics Inc., represented by Richard, Layton & Finger, and Michael M. Goldberg, the CEO of Navidea Biopharmaceuticals Inc. who was supposed to become CEO of its subsidiary, Macrophage.
3 minute read

Delaware Law Weekly

Delaware Suit May Be First of Many Over Bone Graft Linked to Tuberculosis

A case filed in Delaware Superior Court is the first anywhere to claim Aziyo Inc. was negligent in sending out a bone marrow product thought to be contaminated with tuberculosis, but attorneys for the Delaware plaintiff say similar cases are expected to be filed soon.
3 minute read

The Recorder

Weil Reps Bluestar Genomics in Contract Dispute Over DNA Sequencing Tech Used to Assess Cancer

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read

Litigation Daily

A Privilege Lesson from Elizabeth Holmes: Have a Look at Your Engagement Letter. At the Very Least, Have One.

The Theranos founder last week lost out on her bid to keep a batch of emails between her and the company's former lawyers at Boies Schiller Flexner out of her upcoming criminal trial. One thing that weighed against her: The lack of any sort of engagement letter between the firm and the company.
5 minute read

National Law Journal

As FTC Ramps Up Cross-Border Investigations, Mayer Brown Adds Agency Veteran

Gail Levine, now at Mayer Brown, says we can expect a lot more FTC activity after the agency launched a task force as a joint effort between multiple agencies and the Justice Department.
4 minute read

The Recorder

How the Pandemic and Big Tech Backlash Might Be Stretching Technology Transactions

Aarthi Belani, who joined Baker McKenzie's transactional practice from Jones Day, says she's noticed that deals seem to be taking longer to finalize, in part, due to the COVID-19 pandemic and heightened antitrust scrutiny.
6 minute read

Resources

  • Aligning Client Needs with Lawyer Growth and Profitability

    Brought to you by BigHand

    Download Now

  • Technology to Make E-Discovery Smarter, Not Harder

    Brought to you by Nuix

    Download Now

  • Does Generative AI Have the Power to Transform Legal Services?

    Brought to you by HaystackID

    Download Now

  • How This Personal Injury Firm Reduced Client Intake Time by 80%

    Brought to you by PracticePanther

    Download Now